See more : CS Wind Corporation (112610.KS) Income Statement Analysis – Financial Results
Complete financial analysis of United-Guardian, Inc. (UG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of United-Guardian, Inc., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Sumitomo Corporation (SSUMF) Income Statement Analysis – Financial Results
- East Resources Acquisition Company (ERESW) Income Statement Analysis – Financial Results
- Orange Minerals NL (OMX.AX) Income Statement Analysis – Financial Results
- Edison International (0IFJ.L) Income Statement Analysis – Financial Results
- Deutsche Post AG (DHLGY) Income Statement Analysis – Financial Results
United-Guardian, Inc. (UG)
About United-Guardian, Inc.
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder, and localized infections in the peritoneum, as well as eye, ear, nose and throat, and sinuses. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and development primarily related to the development of cosmetic ingredients. It markets its products through marketing partners, distributors, and wholesalers. The company was founded in 1942 and is based in Hauppauge, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.89M | 12.70M | 13.93M | 10.99M | 13.60M | 13.77M | 12.97M | 10.78M | 14.01M | 13.45M | 15.42M | 13.83M | 14.34M | 13.72M | 13.28M | 12.29M | 11.89M | 12.20M | 12.13M | 11.12M | 11.16M | 9.09M | 9.58M | 10.45M | 9.10M | 8.80M | 8.80M | 8.00M | 7.00M | 6.70M | 7.00M | 6.30M | 5.00M | 4.60M | 7.10M | 6.10M | 4.80M | 4.50M |
| Cost of Revenue | 5.48M | 6.00M | 5.75M | 4.87M | 5.66M | 5.67M | 5.30M | 4.88M | 5.20M | 5.32M | 5.61M | 5.22M | 5.65M | 5.25M | 5.32M | 5.41M | 4.85M | 5.64M | 5.69M | 5.07M | 5.06M | 4.90M | 4.65M | 4.76M | 4.60M | 4.40M | 5.00M | 4.90M | 4.20M | 4.20M | 4.10M | 3.60M | 3.00M | 4.40M | 6.70M | 4.40M | 3.40M | 2.80M |
| Gross Profit | 5.41M | 6.70M | 8.18M | 6.11M | 7.94M | 8.10M | 7.67M | 5.89M | 8.80M | 8.13M | 9.81M | 8.61M | 8.69M | 8.47M | 7.95M | 6.88M | 7.03M | 6.55M | 6.44M | 6.05M | 6.10M | 4.19M | 4.93M | 5.68M | 4.50M | 4.40M | 3.80M | 3.10M | 2.80M | 2.50M | 2.90M | 2.70M | 2.00M | 200.00K | 400.00K | 1.70M | 1.40M | 1.70M |
| Gross Profit Ratio | 49.66% | 52.78% | 58.74% | 55.65% | 58.40% | 58.84% | 59.12% | 54.69% | 62.86% | 60.46% | 63.61% | 62.25% | 60.59% | 61.74% | 59.90% | 55.98% | 59.17% | 53.74% | 53.10% | 54.40% | 54.64% | 46.14% | 51.44% | 54.41% | 49.45% | 50.00% | 43.18% | 38.75% | 40.00% | 37.31% | 41.43% | 42.86% | 40.00% | 4.35% | 5.63% | 27.87% | 29.17% | 37.78% |
| Research & Development | 463.99K | 490.77K | 478.64K | 451.21K | 397.39K | 399.52K | 646.08K | 651.83K | 648.21K | 730.41K | 717.00K | 693.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.79M | 1.85M | 1.86M | 2.64M | 2.50M | 2.51M | 2.55M | 3.42M | 2.61M | 2.70M | 2.60M | 2.83M | 2.59M | 2.59M | 2.46M | 2.30M | 2.34M | 2.26M | 2.10M | 2.20M | 2.00M | 2.00M | 1.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.08M | 2.17M | 2.04M | 2.03M | 2.15M | 2.12M | 1.79M | 1.85M | 1.86M | 2.64M | 2.50M | 2.51M | 2.55M | 3.42M | 2.61M | 2.70M | 2.60M | 2.83M | 2.59M | 2.59M | 2.46M | 2.30M | 2.34M | 2.26M | 2.10M | 2.20M | 2.00M | 2.00M | 1.90M | 1.80M | 1.80M | 1.80M | 1.30M | 100.00K | 0.00 | 1.70M | 1.80M | 1.50M |
| Other Expenses | 0.00 | 2.17M | 2.04M | 2.03M | 2.15M | 2.12M | 1.14M | 1.20M | 1.21M | 24.40K | 1.07M | 518.05K | 2.55M | 2.57M | 2.61M | 2.70M | 2.60M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 295.27K | 300.00K | 600.00K | 400.00K | 300.00K | 300.00K | 200.00K | 200.00K | 200.00K | 100.00K | 200.00K | 200.00K | 0.00 | 0.00 | 200.00K |
| Operating Expenses | 2.54M | 2.66M | 2.51M | 2.48M | 2.55M | 2.52M | 2.43M | 2.50M | 2.51M | 2.64M | 2.50M | 2.51M | 2.55M | 3.42M | 2.61M | 2.70M | 2.60M | 2.83M | 2.59M | 2.59M | 2.46M | 2.30M | 2.34M | 2.56M | 2.40M | 2.80M | 2.40M | 2.30M | 2.20M | 2.00M | 2.00M | 2.00M | 1.40M | 300.00K | 200.00K | 1.70M | 1.80M | 1.70M |
| Cost & Expenses | 8.02M | 8.66M | 8.26M | 7.35M | 8.20M | 8.19M | 7.73M | 7.39M | 7.71M | 7.96M | 8.12M | 7.73M | 8.20M | 8.67M | 7.93M | 8.11M | 7.45M | 8.47M | 8.28M | 7.66M | 7.52M | 7.20M | 6.99M | 7.32M | 7.00M | 7.20M | 7.40M | 7.20M | 6.40M | 6.20M | 6.10M | 5.60M | 4.40M | 4.70M | 6.90M | 6.10M | 5.20M | 4.50M |
| Interest Income | 306.65K | 236.70K | 233.86K | 226.25K | 203.33K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 325.02K | 332.65K | 455.79K | 395.26K | 492.44K | 575.03K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 1.62M | 0.00 | 0.00 | 0.00 | 227.98K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 56.00 | 798.00 | 0.00 | 0.00 | 0.00 | 0.00 | 38.00 | 536.00 | 0.00 | 0.00 | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K | 200.00K | 200.00K | 300.00K | 200.00K | 100.00K | 200.00K |
| Depreciation & Amortization | 105.68K | 135.40K | 145.98K | 165.26K | 175.81K | 191.94K | 200.68K | 187.04K | 173.48K | 181.19K | 189.73K | 254.44K | 255.58K | 229.78K | 178.69K | 200.80K | 197.80K | 195.37K | 205.81K | 209.79K | 203.81K | 256.99K | 275.30K | 295.27K | 300.00K | 600.00K | 400.00K | 300.00K | 300.00K | 200.00K | 200.00K | 200.00K | 100.00K | 200.00K | 200.00K | 0.00 | -100.00K | 200.00K |
| EBITDA | 2.97M | 4.17M | 5.81M | 3.80M | 5.57M | 5.77M | 5.44M | 3.58M | 6.47M | 5.67M | 6.16M | 6.35M | 6.39M | 5.29M | 5.52M | 4.38M | 4.64M | 3.86M | 4.06M | 3.67M | 3.85M | 2.15M | 2.87M | 3.42M | 2.40M | 2.10M | 1.80M | 1.10M | 900.00K | 700.00K | 1.10M | 900.00K | 700.00K | 300.00K | 100.00K | -200.00K | -400.00K | -400.00K |
| EBITDA Ratio | 27.27% | 38.17% | 39.17% | 28.32% | 35.01% | 41.35% | 37.94% | 30.34% | 43.80% | 38.86% | 39.96% | 38.12% | 41.76% | 38.53% | 41.59% | 35.72% | 38.92% | 28.75% | 31.48% | 31.03% | 32.95% | 21.52% | 27.43% | 30.50% | 25.27% | 23.86% | 20.45% | 12.50% | 12.86% | 10.45% | 15.71% | 12.70% | 12.00% | -4.35% | 5.63% | -3.28% | -10.42% | 11.11% |
| Operating Income | 2.86M | 4.04M | 5.67M | 3.64M | 5.40M | 5.58M | 5.24M | 3.39M | 6.29M | 5.49M | 7.30M | 6.10M | 6.14M | 5.06M | 5.34M | 4.18M | 4.44M | 3.72M | 3.85M | 3.46M | 3.64M | 1.89M | 2.59M | 3.13M | 2.10M | 1.60M | 1.40M | 800.00K | 600.00K | 500.00K | 900.00K | 700.00K | 600.00K | -100.00K | 200.00K | -200.00K | -400.00K | 300.00K |
| Operating Income Ratio | 26.30% | 31.79% | 40.68% | 33.10% | 39.68% | 40.52% | 40.37% | 31.45% | 44.93% | 40.83% | 47.36% | 44.11% | 42.79% | 36.86% | 40.25% | 34.02% | 37.33% | 30.54% | 31.74% | 31.13% | 32.64% | 20.81% | 27.06% | 29.95% | 23.08% | 18.18% | 15.91% | 10.00% | 8.57% | 7.46% | 12.86% | 11.11% | 12.00% | -2.17% | 2.82% | -3.28% | -8.33% | 6.67% |
| Total Other Income/Expenses | 387.75K | -809.55K | 210.84K | 524.83K | 634.41K | -113.99K | 315.17K | 306.51K | 331.83K | 264.00K | 1.33M | 828.21K | 736.09K | 455.79K | 395.68K | 484.68K | 583.93K | 470.11K | 237.46K | 220.99K | 169.34K | 192.10K | 239.08K | 237.61K | 100.00K | 0.00 | -100.00K | 0.00 | -100.00K | -300.00K | -200.00K | -100.00K | -100.00K | 100.00K | 100.00K | 200.00K | -100.00K | -100.00K |
| Income Before Tax | 3.25M | 3.23M | 5.88M | 4.16M | 6.03M | 5.47M | 5.55M | 3.70M | 6.63M | 5.75M | 8.63M | 6.93M | 6.87M | 5.51M | 5.74M | 4.67M | 5.02M | 4.14M | 4.09M | 3.68M | 3.81M | 2.08M | 2.83M | 3.37M | 2.20M | 1.60M | 1.30M | 800.00K | 500.00K | 200.00K | 700.00K | 600.00K | 500.00K | 0.00 | 300.00K | 0.00 | -500.00K | 500.00K |
| Income Before Tax Ratio | 29.86% | 25.42% | 42.20% | 37.88% | 44.34% | 39.70% | 42.80% | 34.30% | 47.30% | 42.79% | 55.99% | 50.10% | 47.92% | 40.18% | 43.23% | 37.97% | 42.25% | 33.92% | 33.70% | 33.11% | 34.16% | 22.92% | 29.55% | 32.22% | 24.18% | 18.18% | 14.77% | 10.00% | 7.14% | 2.99% | 10.00% | 9.52% | 10.00% | 0.00% | 4.23% | 0.00% | -10.42% | 11.11% |
| Income Tax Expense | 669.41K | 658.17K | 1.22M | 856.02K | 1.27M | 1.11M | 1.71M | 1.11M | 2.02M | 1.70M | 2.73M | 2.10M | 2.16M | 1.71M | 1.86M | 1.50M | 1.60M | 1.40M | 1.47M | 1.21M | 1.34M | 662.34K | 941.06K | 1.31M | 800.00K | 600.00K | 500.00K | 300.00K | 200.00K | 100.00K | 200.00K | 200.00K | 200.00K | 500.00K | 300.00K | -200.00K | -100.00K | 200.00K |
| Net Income | 2.58M | 2.57M | 4.66M | 3.30M | 4.76M | 4.35M | 3.84M | 2.58M | 4.61M | 4.05M | 5.90M | 4.83M | 4.72M | 3.80M | 3.88M | 3.16M | 3.54M | 2.74M | 2.62M | 2.48M | 2.47M | 1.42M | 1.89M | 2.05M | 1.40M | 1.00M | 800.00K | 500.00K | 300.00K | 100.00K | 500.00K | 600.00K | 300.00K | -600.00K | 0.00 | -200.00K | -400.00K | 100.00K |
| Net Income Ratio | 23.71% | 20.23% | 33.44% | 30.08% | 35.01% | 31.61% | 29.64% | 23.95% | 32.89% | 30.12% | 38.29% | 34.94% | 32.89% | 27.69% | 29.22% | 25.73% | 29.81% | 22.44% | 21.57% | 22.25% | 22.15% | 15.64% | 19.73% | 19.65% | 15.38% | 11.36% | 9.09% | 6.25% | 4.29% | 1.49% | 7.14% | 9.52% | 6.00% | -13.04% | 0.00% | -3.28% | -8.33% | 2.22% |
| EPS | 0.56 | 0.56 | 1.01 | 0.72 | 1.04 | 0.95 | 0.84 | 0.56 | 1.00 | 0.88 | 1.28 | 1.05 | 1.03 | 0.80 | 0.78 | 0.64 | 0.72 | 0.55 | 0.53 | 0.50 | 0.50 | 0.29 | 0.39 | 0.42 | 0.28 | 0.21 | 0.17 | 0.11 | 0.06 | 0.03 | 0.10 | 0.12 | 0.06 | -0.12 | 0.00 | -0.05 | -0.07 | 0.02 |
| EPS Diluted | 0.56 | 0.56 | 1.01 | 0.72 | 1.04 | 0.95 | 0.84 | 0.56 | 1.00 | 0.88 | 1.28 | 1.05 | 1.03 | 0.80 | 0.78 | 0.64 | 0.72 | 0.55 | 0.53 | 0.50 | 0.50 | 0.29 | 0.39 | 0.42 | 0.28 | 0.21 | 0.17 | 0.11 | 0.06 | 0.03 | 0.10 | 0.12 | 0.06 | -0.12 | 0.00 | -0.05 | -0.07 | 0.02 |
| Weighted Avg Shares Out | 4.59M | 4.59M | 4.59M | 4.59M | 4.59M | 4.58M | 4.59M | 4.59M | 4.59M | 4.60M | 4.60M | 4.60M | 4.60M | 4.74M | 4.95M | 4.95M | 4.94M | 4.94M | 4.94M | 4.93M | 4.90M | 4.88M | 4.87M | 4.88M | 4.89M | 4.88M | 4.71M | 4.55M | 5.00M | 5.00M | 5.00M | 5.00M | 5.00M | 5.00M | 4.76M | 4.00M | 5.71M | 4.80M |
| Weighted Avg Shares Out (Dil) | 4.59M | 4.59M | 4.59M | 4.59M | 4.59M | 4.58M | 4.59M | 4.59M | 4.59M | 4.60M | 4.60M | 4.60M | 4.60M | 4.74M | 4.95M | 4.95M | 4.95M | 4.94M | 4.94M | 4.94M | 4.91M | 4.89M | 4.89M | 4.91M | 4.91M | 4.90M | 4.71M | 4.55M | 5.00M | 5.00M | 5.00M | 5.00M | 5.00M | 5.00M | 4.76M | 4.00M | 5.71M | 4.80M |
United-Guardian's Business Is Under Threat, And The Stock Is Still Expensive
United Airlines is buying at least 100 Boeing Dreamliners to replace aging wide-body jets
Gold rises for third day as dollar, Treasury yields pull back
Gold rises for second day, bolstered by dollar's pullback
Gold rises as European inflation data undermines dollar
Energy and agriculture prices to remain elevated through 2022, gold price to see only modest gains - World Bank
U.S. new home sales fall short of expectations in March, gold price edges up above $1,900
Gold price modestly up as bulls work to stabilize market
Where is the next support area for the gold price?
Gold price gives up $1,900 and silver falls below $24 an ounce, analysts see room for lower prices
Source: https://incomestatements.info
Category: Stock Reports